EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY.

Subjects

Subjects :

*CARDIAC amyloidosis
*QUALITY of life
*BORTEZOMIB
*CYCLOPHOSPHAMIDE
*DEXAMETHASONE

Details

Language :

English

ISSN :

07351097

Volume :

77

Issue :

18

Database :

Academic Search Index

Journal :

Journal of the American College of Cardiology (JACC)

Publication Type :

Academic Journal

Accession number :

149884108

Full Text :

https://doi.org/10.1016/S0735-1097(21)04658-1